Financial Performance - Total revenue for Q3 2024 was $478.7 million, a 37% increase from $348.2 million in Q3 2023[3] - Care Partners revenue reached $455.8 million, up 42% from $320.9 million year-over-year[3] - Net income attributable to Astrana decreased by 27% to $16.1 million from $22.1 million in the same quarter last year[3] - Adjusted EBITDA for Q3 2024 was $45.2 million, down 13% from $52.0 million in Q3 2023[3] - Total revenue for the three months ended September 30, 2024, was $478,710,000, a 37.5% increase from $348,173,000 in the same period of 2023[20] - Net income for the three months ended September 30, 2024, was $18,981,000, compared to $27,973,000 in the same period of 2023, reflecting a decrease of 32.1%[20] - Adjusted EBITDA for the three months ended September 30, 2024, was $45,170,000, down 13% from $51,974,000 in the same period last year[22] - Adjusted EBITDA margin decreased to 9% for the three months ended September 30, 2024, compared to 15% for the same period in 2023[22] Revenue Guidance - 2024 revenue guidance is raised to a range of $1,950 million to $2,030 million[8] - Net income guidance for 2024 is set between $52 million and $58 million[8] - Adjusted EBITDA guidance for 2024 is projected between $165 million and $175 million[8] - Diluted EPS guidance for 2024 is expected to be between $1.06 and $1.19[8] - The company provided guidance for 2024 with a net income range of $59,340,000 to $66,240,000[25] - The guidance for Adjusted EBITDA in 2024 is projected to be between $165,000,000 and $175,000,000[25] Assets and Liabilities - Total current assets increased to $596,990,000 in 2024 from $461,507,000 in 2023, representing a growth of 29.3%[17] - Total assets rose to $1,285,376,000 in 2024, up from $933,361,000 in 2023, marking an increase of 37.7%[19] - Total liabilities increased to $778,269,000 in 2024 from $522,593,000 in 2023, an increase of 48.8%[19] - Cash and cash equivalents grew to $347,994,000 in 2024, up from $293,807,000 in 2023, a rise of 18.4%[17] - The company’s total non-current assets increased to $688,386,000 in 2024 from $471,854,000 in 2023, a growth of 45.8%[17] - The company’s retained earnings increased to $293,234,000 in 2024 from $243,134,000 in 2023, reflecting a growth of 20.6%[19] Other Financial Metrics - The company reported a capitation revenue of $431,401,000 for the three months ended September 30, 2024, compared to $305,678,000 in 2023, an increase of 41.1%[20] - Earnings per share (diluted) for the three months ended September 30, 2024, was $0.33, down from $0.47 in the same period of 2023[20] - Interest expense increased significantly to $8,856,000 for the three months ended September 30, 2024, compared to $3,779,000 for the same period in 2023[22] - Provision for income taxes was $7,831,000 for the three months ended September 30, 2024, down from $10,042,000 in the same period last year[22] - Stock-based compensation increased to $6,163,000 for the three months ended September 30, 2024, compared to $5,706,000 for the same period in 2023[22] - The company reported a loss from equity method investments of $(1,353,000) for the three months ended September 30, 2024, compared to a gain of $2,016,000 in the same period last year[22] Acquisitions - The company closed the acquisition of Collaborative Health Systems, LLC and other entities for $37.5 million, with potential earnout payments of up to $21.5 million[4]

Core Insights - Astrana Health, Inc. reported strong financial results for the third quarter ended September 30, 2024, with total revenue of $478.7 million, a 37% increase from $348.2 million in the same period last year [3][4] - The company continues to experience organic and inorganic growth, emphasizing its commitment to delivering high-quality care to approximately 1.1 million patients nationwide [2][3] Financial Highlights for Q3 2024 - Total revenue reached $478.7 million, up 37% from $348.2 million [3] - Care Partners revenue was $455.8 million, reflecting a 42% increase from $320.9 million [3] - Net income attributable to Astrana decreased to $16.1 million, down 27% from $22.1 million [3] - Diluted earnings per share (EPS) was $0.33, a 30% decline from $0.47 [3] - Adjusted EBITDA was $45.2 million, down 13% from $52.0 million [3] Financial Highlights for Nine Months Ended September 30, 2024 - Total revenue for the nine months was $1,369.3 million, a 32% increase from $1,033.6 million [4] - Care Partners revenue for the nine months was $1,301.4 million, up 36% from $957.3 million [4] - Net income attributable to Astrana increased to $50.1 million, up 4% from $48.4 million [4] - Diluted EPS was $1.04, a slight increase from $1.03 [4] - Adjusted EBITDA for the nine months was $135.3 million, up 15% from $117.6 million [4] Recent Operating Highlights - On October 4, 2024, Astrana completed the acquisition of Collaborative Health Systems, LLC, and other entities for a total purchase price of $37.5 million, with potential earnout payments of up to $21.5 million [5] Segment Results for Q3 2024 - Care Partners revenue was $455.8 million, a 42% increase year-over-year [6] - Care Delivery revenue was $34.7 million, a 20% increase [6] - Care Enablement revenue was $40.9 million, an 11% increase [6] - Total expenses for the quarter were $450.3 million, leading to an income from operations of $28.4 million [6] 2024 Guidance - The company raised its revenue guidance for the year, projecting total revenue between $1,950 million and $2,030 million [8][9] - Net income guidance is set between $52 million and $58 million, with Adjusted EBITDA expected to be between $165 million and $175 million [9]

ALHAMBRA, Calif., Oct. 23, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2024, after the close of the stock market on Thursday, November 7, 2024. The Company will dis ...

ALHAMBRA, Calif., Oct. 7, 2024 /PRNewswire/ --– Astrana Health, Inc. ("Astrana"), together with its subsidiaries and affiliated entities ("the Company") (NASDAQ: ASTH), a leading provider-centric, technologypowered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced it has closed its transaction to acquire Collaborative Health Systems ("CHS"), a management services organization serving more than 129,000 beneficiaries across 17 states and pre ...

ALHAMBRA, Calif., Aug. 22, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technologypowered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences: The Wells Fargo Healthcare Conference, being held in Boston, on Wednesday, September 4, 2024. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___. Commission File No. 001-37392 Astrana Health, Inc. (Exact name of registrant as specified in its charter) Delaware 95-4472349 (State or Other Jurisdiction (I. ...

Astana Health, Inc. (NASDAQ:ASTH) Q2 2024 Results Conference Call August 7, 2024 5:30 PM ET Company Participants Brandon Sim - President & Chief Executive Officer Chan Basho - Chief Operating & Financial Officer Conference Call Participants Jailendra Singh - Truist Securities Adam Rahn - Bank of America Ryan Daniels - William Blair David Larsen - BTIG Brooks O'Neil - Lake Street Capital Jack Slevin - Jefferies Michael Ha - Baird Craig Jones - Stifel Ryan Langston - TD Cowen Operator Good day everyone and we ...

Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 5.26%. A quarter ago, it was expected that this company would post earnings of $0.32 per share when it actually produced earnings of $0.31, delivering a surprise of -3.13%. Over the last four quarters, the co ...

Exhibit 99.1 +. Astrana Health Astrana Health, Inc. Reports Second Quarter 2024 Results Company to Host Conference Call on Wednesday, August 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., August 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today anno ...

Company to Host Conference Call on Wednesday, August 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET Three Months Ended June 30, 2024 ALHAMBRA, Calif., Aug. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, highquality, and high-value care to all, today announced its consolidated financial results for the second qu ...